Presence and function of dopamine D1 receptors in the rat ventral tegmental area

Polish Journal of Pharmacology

Volumn 49, Issue 5, 1997, Pages 277-281

  Wedzony, Krzysztof ^a   Czyrak, Anna ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Dopamine D1 receptors; SCH 23390; Sensitization; Ventral tegmental area

Indexed keywords

DOPAMINE 1 RECEPTOR;

ANIMAL TISSUE; CONTROLLED STUDY; NONHUMAN; RAT; REVIEW; SENSITIZATION; VENTRAL TEGMENTUM;

ANIMALS; AUTORADIOGRAPHY; CENTRAL NERVOUS SYSTEM STIMULANTS; MOTOR ACTIVITY; RATS; RECEPTORS, DOPAMINE D1; SYNAPTIC TRANSMISSION; VENTRAL TEGMENTAL AREA;

EID: 0030727109     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Bischoff S., Heinrich M., Sonntag J. M., Krauss J.: The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors. Eur. J. Pharmacol., 1986, 129, 367-370.
2. Bjijou Y., Stinus L., Le Moal M., Cador M.: Evidence for selective involvement of dopamine D1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of D-amphetamine. J. Pharmacol. Exp. Ther., 1996, 277, 1177-1187.
3. Cador M., Bjijou Y., Stinus L.: Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience, 1995, 65, 385-395.
4. Deutch A. Y: Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease. J. Neural Transm. - Gen. Sect., 1993, 91, 197-221.
5. Kalivas P. W.: Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Rev., 1993, 18, 75-113.
6. Kalivas P. W., Alesdatter J. E.: Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther., 1993, 267, 486-495.
7. Kalivas P. W., Duffy P.: D1 receptors modulate glutamate transmission in the ventral tegmental area. J. Neurosci., 1995, 15, 5379-5388.
8. Kalivas P. W., Stewart J.: Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev., 1991, 16, 223-244.
9. Koob G. F., Nestler E. J.: The neurobiology of drug addiction. J. Neuropsychiatr. Clin. Neurosci., 1997, 9, 482-497.
10. LuX, Y., Churchill L., Kalivas P. W.: Expression of D1 receptor mRNA in projections from the forebrain to the ventral tegmental area. Synapse, 1997, 25, 205-214.
11. Maj J., Wedzony K., Klimek V.: Desipramine given repeatedly enhances behavioural effects of dopamine and d-amphetamine injected into the nucleus accumbens. Eur. J. Pharmacol., 1987, 140, 179-185.
12. Mansour A., Meador-Woodruff J. H., Zhou Q., Civelli O., Akil H., Watson S. J.: A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques. Neuroscience, 1992, 46, 959-971.
13. Meador-Woodruff J. H., Mansour A., Healy D. J., Kuehn R., Zhou Q. Y., Bunzow J. R., Akil H., Civelli O., Watson S. J. Jr.: Comparison of the distributions of Dl and D2 dopamine receptor mRNAs in rat brain. Neuropsychopharmacology, 1991, 5, 231-242.
14. O'Connor S. E.: The pharmacology of sulpiride - a dopamine receptor antagonist. Gen. Pharmacol., 1982, 13, 185-193.
15. Piazza P. V., Maccari S., Deminiere J. M., Le Moal M., Mormede P., Simon H.: Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc. Nat. Acad. Sci. USA, 1991, 88, 2088-2092.
16. Piazza P.V., Marinelli M., Rouge-Pont F., Deroche V., Maccari S., Simon H., Le Moal M.: Stress, glucocorticoids, and mesencephalic dopaminergic neurons: a pathophysiological chain determining vulnerability to psychostimulant abuse. NIDA Res. Monogr., 1996, 163, 277-299.
17. Pierce R. C., Born B., Adams M., Kalivas P. W.: Repeated intra-ventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge. J. Pharmacol. Exp. Ther., 1996, 278, 384-392.
18. Robinson T. E., Berridge K. C.: The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev., 1993, 18, 247-291.
19. Stewart J., Vezina P.: Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine. Brain Res., 1989, 495, 401-406.
20. Vezina P.: D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area. J. Neurosci., 1996, 16, 2411-2420.
21. Vezina P., Stewart J.: The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res., 1989, 499, 108-120.
22. Wedzony K., Czyrak A., Maćkowiak M., Fijał K.: The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra. Naunyn-Schmied. Arch, Pharmacol., 1996, 353, 517-527.
23. Wolf M.E., White F.J., Hu X. T.: MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. J. Neurosci., 1994, 14, 1735-1745.